V

Velocity Clinical Research | Dallas, TX

Research site

(Unclaimed)

Location

7777 Forrest Lane, Suite C685, Dallas, Texas, United States of America

Site insights

Top conditions

Top treatments

RO7795081

RGT001-075

BMF-219

CRB-913

ION224

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

Locations recently updated

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes (Enith2)

The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropi...

Enrolling

Obesity or Overweight

Type 2 Diabetes Mellitus

Combination Product: Enicepatide

Combination Product: Placebo

A Study to Compare Different Doses of RO7795081 With Placebo or Semaglutide in People With Type 2 Diabetes

This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: Placebo

Drug: RO7795081